Smoking Cessation Program in the Preadmission Clinic

• Status: Completed
• Trial end date: 2017-04-01
• Target enrollment: 0
• Participant gender: All

Summary

Main Hypothesis: The multifaceted intervention (preoperative counseling, pharmacotherapy by varenicline and follow up by quit line) in the preoperative clinic is more effective than the simple preoperative smoking intervention (brief advice and provision of information about the quit lines ) in terms of short-term and long-term quit rates

Objectives: To evaluate the effectiveness and feasibility of a multifaceted intervention (preoperative counseling, pharmacotherapy by varenicline and follow up by the quit line) in the preoperative clinic to help surgical patients quit smoking perioperatively and for the long-term.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Health Network, Toronto
• Collaborator: Pfizer

Criteria

Inclusion Criteria:

• Patients who smoke more than 10 cigarettes per day for more than 1 year

• And had no period of smoking abstinence longer than 3 months in the past year.

• Patients who are scheduled to have any elective surgery next 7 to 60 days. Patients > 18 years of age

Exclusion Criteria:

• Patients unwilling or unable to give informed consent

• Patients who are pregnant and breast feeding

• Patients with any psychiatric disorder

• Patients who used nicotine replacement / bupropion within previous 3 months

• Cardiovascular disease within the past 6 months

• Any serious or unstable disease within the past 6 months

• Drug or alcohol abuse within the past year.